Clinical trial
Observational Study of the Durability of Seroconversion Chronic HBV Patients Who…
NCT00158717 · Gilead Sciences, Industry · Completed
Key facts
| NCT number | NCT00158717 |
|---|---|
| Title | Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV. |
| Official title | A Phase 3b, Long-Term, Observational Study of the Durability of Seroconversion in Patients With Chronic Hepatitis B Virus Infection Who Have Seroconverted While Participating in a Previous Gilead-Sponsored Study of Adefovir Dipivoxil. |
| Lead sponsor | Gilead Sciences, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Hepatitis B |
| Intervention type | Drug |
| Interventions | Hepsera |
| Enrollment | 107 |
| Start date | Apr 1, 2003 |
| Primary completion | Apr 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Jan 7, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: